Showing 1 - 6 results of 6 for search 'Jonathan P. Law', query time: 0.03s Refine Results
  1. 1
    Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients

    Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients by Jonathan P. Law, Richard Borrows, David McNulty, Adnan Sharif, Charles J. Ferro

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta‐analysis

    Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta‐analysis by Luke C. Pickup, Jonathan P. Law, Ashwin Radhakrishnan, Anna M. Price, Charalampos Loutradis, Toby O. Smith, Nicola C. Edwards, Richard P. Steeds, Jonathan N. Townend, Charles J. Ferro

    Published 2021-06-01
    Get full text
    Article
  3. 3
    Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease

    Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease by Ashwin Radhakrishnan, Luke C. Pickup, Anna M. Price, Jonathan P. Law, Kirsty C. McGee, Larissa Fabritz, Roxy Senior, Richard P. Steeds, Charles J. Ferro, Jonathan N. Townend

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype

    Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype by Caitlin Hall, Jonathan P. Law, Jasmeet S. Reyat, Max J. Cumberland, Shaun Hang, Nguyen T. N. Vo, Kavita Raniga, Chris J. Weston, Christopher O’Shea, Jonathan N. Townend, Katja Gehmlich, Charles J. Ferro, Chris Denning, Davor Pavlovic

    Published 2023-07-01
    Get full text
    Article
  5. 5
    Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy

    Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy by Jonathan P. Law, Anna M. Price, Luke Pickup, Ashwin Radhakrishnan, Chris Weston, Alan M. Jones, Helen M. McGettrick, Winnie Chua, Richard P. Steeds, Larissa Fabritz, Paulus Kirchhof, Davor Pavlovic, Jonathan N. Townend, Charles J. Ferro

    Published 2020-04-01
    Get full text
    Article
  6. 6
    Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.

    Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A valida... by Winnie Chua, Jonathan P Law, Victor R Cardoso, Yanish Purmah, Georgiana Neculau, Muhammad Jawad-Ul-Qamar, Kalisha Russell, Ashley Turner, Samantha P Tull, Frantisek Nehaj, Paul Brady, Peter Kastner, André Ziegler, Georgios V Gkoutos, Davor Pavlovic, Charles J Ferro, Paulus Kirchhof, Larissa Fabritz

    Published 2021-02-01
    Get full text
    Article

Search Tools: